| 摘要 |
The present invention relates to a process for the preparation of a cis-intermediate compound of Formula II which is a useful synthetic intermediate for the preparation of tadalafil of Formula I—a potent, selective, and reversible inhibitor of cyclic guanosine 3′,5′-monophosphate specific phosphodiesterase type 5 enzyme having phosphodiesterase inhibitory activity. |
